Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclic Desogestrel for Anovulatory DUB
NCT02103764Phase 3Unknown
- Sponsor
- Mahidol University
- Start
- Aug 2013
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of desogestrel in dysfunctional uterine bleeding (DUB) (2 arms), sponsored by Mahidol University. Primary endpoint: The change in endometrial histology. Status: unknown.
02
Drugs
desogestrel
03
Conditions
dysfunctional uterine bleeding (DUB)
Beyond the preview
Go deeper on NCT02103764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103764.